- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04730908
Dentifrice With Innovative Remineralizing Technology (REFIX)
Study Overview
Detailed Description
A randomized, duple-blind crossover clinical trial study was performed to evaluate the bioavailability of intraoral fluoride in biomarkers of exposure (biofilm and saliva) after the use of dentifrice with experimental fluoride for one week, with wash-out periods between them. The biofilm was collected 1 hour (h) and 12h after toothbrushing, and saliva was collected 1h (T1, T15, T30, T45, T60 min) and 12h. The data was obtained by potentiometry (ion selective electrode) for fluoride in these samples.
Study population The sample size was determined by sample calculation [25], according to previous studies [26], α = 5%, β = 10%, and a dropout ratio of 10%. Eighteen individuals with an average of 26 years old, including both males and females, participated in this study. The eligibility criteria were people over 18 years old, without systemic commitment and living in the city of João Pessoa-Paraíba, without water fluoridation (< 0.1 μg/mL F). Individuals were excluded if they used drugs that interfere with biofilm formation and salivary flow or fluoride products (> 5000 ppm) in the last 4 weeks, used orthodontic appliances, or had cavity lesions, periodontal disease, and/or tooth sensitivity.
Experimental Dentifrices The participants were allocated randomly to use the following experimental dentifrices according to table 1. They were coded by an independent investigator not involved in the trial. A simple randomization was performed taking into account a cross design. The unit of randomization was "dentifrice", so all dentifrices had the same chance of being selected. The design of the study was created for each participant and for each new one another draw was made.
Clinical Stage First, the participants were submitted to dental prophylaxis and scraping to remove all biofilm and dental calculus. They used a placebo, dentifrice without fluoride, for 7 days. Then, the Whitford protocol was followed [16]. Briefly, the subjects were instructed to brush their teeth three times/day for 1 min (transversal technique) and also to rinse their mouths after brushing with 10 mL of water. On the seventh day, the subjects were instructed to brush only the occlusal surfaces and do not use dental floss, to allow biofilm accumulation. After going to bed, they abstained from eating or drinking anything except water and did not brush their teeth. The next morning, after 12 hours of last brushing, and fasting, the first samples of saliva and biofilm (upper and lower right hemi-arch) were collected. Then, the volunteers brushed the occlusal surfaces for 1 min. Soon after, saliva samples were collected in the following times: t1, t15, t30, t45, and t60 minutes. Biofilme samples (left side) were collected later (1 hour after brushing). Resting saliva was collected for 5 minutes. The biofilm was collected from all tooth surfaces, in both buccal and lingual areas, using a 3S hollenback spatula, from which the samples were immediately transferred to an eppendorff tube, centrifuged and subsequently dried at 90°C for two hours and then weighed. The saliva samples were centrifuged at 6,000 rpm for 10 minutes in order to separate the saliva debris.
Determination of the concentration of fluoride The samples were analyzed by the hexamethyldisiloxane (HMDS) facilitated diffusion method of Taves [20] modified by Whitford [21]. The analyzes were performed with a fluoride specific electrode (model 9409; Orion Research) and a potentiometer (model EA 940; Orion Research, Cambridge, MA, USA) (Model 720 A Orion). Fluoride standards (1-100 nM) were used to prepare calibration curves.
Statistical analysis The data were analyzed using descriptive and inferential statistics, using the statistical program SPSS - v. 21.0 and software Graphpad. The Shapiro-Wilk test was applied to test the normality of the in vivo study data (n <50). Nonparametric tests were performed. The area under the curve (AUC) was calculated by taking baseline values (12 h after the last brush) up to 60 min after the last brush to indicate the effectiveness of F retention in saliva over time. For the purpose of comparing the concentration of F in saliva and biofilm between the groups, the ANOVA test of repeated measures was performed followed by the Bonferroni post-test. The relationship between the concentrations of biofilm and salivary fluoride was determined using Spearman's correlation coefficient. This study assumed a significance level of 5% (p <0.05).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: ANDRESSA FEITOSA, PhD
- Phone Number: +558332167795
- Email: andressafeitosaboliveira@gmail.com
Study Contact Backup
- Name: NAYANNA SOARES, Master
- Phone Number: +558332167955
- Email: fernandesnayanna58@gmail.com
Study Locations
-
-
Paraíba
-
João Pessoa, Paraíba, Brazil
- Recruiting
- Federal University of Paraiba
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The eligibility criteria were people over 18 years old, without systemic commitment and living in the city of João Pessoa-Paraíba, without water fluoridation (< 0.1 μg/mL F).
Exclusion Criteria:
- Individuals were excluded if they used drugs that interfere with biofilm formation and salivary flow or fluoride products (> 5000 ppm) in the last 4 weeks, used orthodontic appliances, or had cavity lesions, periodontal disease, and/or tooth sensitivity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: G0 - placebo
Dental gel without fluoride in the composition
|
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Names:
|
SHAM_COMPARATOR: G1: Daily Regenerator Dentalclean Neutro (RDCN)
1450 ppm F- of sodium fluoride and tetrasodium pyrophosphate (Refix technology).
NEUTRAL pH
|
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Names:
|
ACTIVE_COMPARATOR: G2: Sensodyne Repair & Protect (SRP)
1426 ppm of sodium fluoride and calcium sodium phosphosilicate 5% (NOVAMIN technology).
|
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Names:
|
EXPERIMENTAL: G3: Daily Regenerator Dentalclean Acid (RDCA)
1450 ppm F- of sodium fluoride and tetrasodium pyrophosphate (Refix technology).
ACIDIC FORMULA
|
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Names:
|
ACTIVE_COMPARATOR: G4: Colgate Total Daily Repair (CTDR)
1450 ppm F- of as sodium fluoride, 0.30% triclosan, arginine, tetrasodium pyrophosphate.
|
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FLUORIDE IN SALIVA
Time Frame: 12 hours
|
Concentration of fluoride in saliva after brushing teeth
|
12 hours
|
FLUORIDE IN DENTAL PLAQUE
Time Frame: 12 hours
|
Concentration of fluoride in dental biofilm after brushing teeth
|
12 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: FABIO SAMPAIO, PhD, Universidade Federal da Paraíba
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REFIX-UFPB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Initial Dental Caries
-
Hue University of Medicine and PharmacyRecruitingOcclusal Caries | Caries,Dental | Caries; InitialVietnam
-
CareQuest Institute for Oral HealthActive, not recruitingDental Caries in Children | Dental Caries | Initial Caries | Arrested Dental Caries | Cavitated CariesUnited States
-
Wuhan UniversityUnknown
-
Dow University of Health SciencesUniversity of KarachiRecruitingDental Caries | White Spot Lesion | Initial Caries | Incipient Enamel CariesPakistan
-
Cairo UniversityNot yet recruiting
-
Plovdiv Medical UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingPit and Fissure Caries | Caries; InitialEgypt
-
Universidad Rey Juan CarlosRecruitingInitial Proximal CariesSpain
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityCompleted
Clinical Trials on DENTIFRICE
-
Procter and GambleCompleted
-
HALEONCompleted
-
Fabio Correia SampaioCompleted
-
GlaxoSmithKlineCompleted
-
Sun Yat-sen UniversityWest China College of StomatologyCompletedGingivitis | Dental PlaqueChina
-
Sun Yat-sen UniversityCompletedDentine HypersensitivityChina
-
Fabio Correia SampaioUnknown
-
Ajman UniversityA B Shetty Memorial Institute of Dental ScienceCompletedPlaque, Dental | Gingiva; InfectionIndia
-
HALEONCompletedTooth ErosionUnited States
-
GlaxoSmithKlineCompleted